Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

(2015) B. A. M. Heemskerk-Gerritsen et al.   JNCI-Journal of the National Cancer Institute

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

(2015) B. A. M. Heemskerk-Gerritsen et al.   JNCI-Journal of the National Cancer Institute

RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1

(2015) Purna A. Joshi et al.   Stem Cell Reports

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

(2014) Joanne Kotsopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

(2013) Rowan T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

The sex hormone system in carriers of BRCA1/2 mutations: a case-control study

(2013) Martin Widschwendter et al.   LANCET ONCOLOGY

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial

(2012) Garnet L Anderson et al.   LANCET ONCOLOGY

Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy

(2011) V. Beral et al.   JNCI-Journal of the National Cancer Institute

Hormone replacement therapy and the risk of breast cancer

(2011) Steven A. Narod   Nature Reviews Clinical Oncology

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

(2010) Eva Gonzalez-Suarez et al.   NATURE

Progesterone induces adult mammary stem cell expansion

(2010) Purna A. Joshi et al.   NATURE

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

(2010) Daniel Schramek et al.   NATURE

The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

(2009) C. R. Eheman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

(2008) Kelly A. Metcalfe et al.   INTERNATIONAL JOURNAL OF CANCER

Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis

(2008) Kathryn B. Horwitz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

(2008) A. Eisen et al.   JNCI-Journal of the National Cancer Institute

Declining breast cancer incidence and decreased HRT use

(2008) Merethe Kumle   LANCET

Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts

(2008) K. B. Horwitz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA